At the outset of the new year, LCGC International engaged with leading experts in the field to identify the major and ...

Governor Wes Moore announced December 23, 2025, that Maryland has exceeded all targets set under the Governor’s ...

Jacobio Pharma (1167.HK,) today announced that it has entered an agreement with AstraZeneca for its proprietary Pan-KRAS inhibitor JAB-23E73. AstraZeneca will receive exclusive development and ...

AstraZeneca says it expects to invest $2 billion to expand its long-standing manufacturing footprint in Maryland. This includes a significant expansion of its flagship biologics manufacturing facility ...

Frederick, MD — Gov. Wes Moore on Friday announced that AstraZeneca will invest $2 billion to expand its operations in Maryland in what he described as the “single largest private investment in ...

DEVELOPMENTS FROM FREDERICK. THE INVESTMENT PROVIDES AN ECONOMIC SHOT IN THE ARM, CREATES JOBS AND BOOSTS THE STATE’S EFFORT TO EXPAND MARYLAND’S LIFE SCIENCES SECTOR. TODAY IS ABOUT SHOWING THAT WE ...

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca today announces plans to invest $2 billion to expand its long-standing manufacturing footprint in Maryland. This includes a significant expansion of its ...

AstraZeneca Plc (NASDAQ:AZN) shared on Monday full data from the Bax24 Phase 3 trial of once-daily 2mg baxdrostat versus placebo, on the reduction of ambulatory systolic blood pressure (SBP), as well ...

AstraZeneca has ended work on one of its potential drugs for fatty liver disease after viewing disappointing data from a phase 2 study. The U.K.-based pharma had been evaluating the antisense ...

This is read by an automated voice. Please report any issues or inconsistencies here. AstraZeneca becomes second major pharmaceutical company to agree to lower Medicaid drug prices under Trump ...

Pharmaceutical giant AstraZeneca will offer U.S. patients discounted prices for some prescription drugs, President Trump announced Friday, the second major drug company to strike a deal with the Trump ...

President Donald Trump announced on Friday a deal with drugmaker AstraZeneca in his latest effort to lower drug costs through so-called “Most Favored Nation” pricing. The move comes after the ...